Scribe Therapeutics Inc (SCTX) PT Raised to $58 at Leerink Aug 25, 2026 06:07AM
Leerink Starts Scribe Therapeutics Inc (SCTX) at Outperform Aug 18, 2026 06:07AM
Wells Fargo Starts Scribe Therapeutics Inc (SCTX) at Overweight Aug 18, 2026 04:56AM
Guggenheim Starts Scribe Therapeutics Inc (SCTX) at Buy Aug 18, 2026 03:44AM
Goldman Sachs Starts Scribe Therapeutics Inc (SCTX) at Early-Stage Biotech Aug 18, 2026 02:32AM


Jul 24, 2026 11:05AM Scribe Therapeutics indicating open above $29, IPO priced at $15
Jul 20, 2026 07:19AM Scribe Therapeutics files for 7.15M share IPO at $13-$15/sh
Jul 10, 2026 05:00PM Scribe Therapeutics Files for Nasdaq IPO
Jul 2, 2026 04:49PM Scribe Therapeutics files for proposed Nasdaq IPO